Stephen S. Phd Tang Sells 23,333 Shares of OraSure Technologies, Inc. (OSUR) Stock
OraSure Technologies, Inc. (NASDAQ:OSUR) Director Stephen S. Phd Tang sold 23,333 shares of the stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $17.97, for a total value of $419,294.01. Following the completion of the sale, the director now directly owns 59,749 shares of the company’s stock, valued at $1,073,689.53. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of OraSure Technologies, Inc. (OSUR) opened at $17.86 on Wednesday. The firm has a market capitalization of $1,080.00, a P/E ratio of 35.02, a PEG ratio of 5.10 and a beta of 1.42. OraSure Technologies, Inc. has a fifty-two week low of $10.75 and a fifty-two week high of $23.01.
OraSure Technologies (NASDAQ:OSUR) last posted its quarterly earnings data on Wednesday, February 7th. The medical instruments supplier reported $0.12 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.11 by $0.01. The business had revenue of $52.00 million during the quarter, compared to the consensus estimate of $50.20 million. OraSure Technologies had a return on equity of 13.09% and a net margin of 18.52%. The company’s revenue was up 46.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.13 earnings per share. research analysts anticipate that OraSure Technologies, Inc. will post 0.29 EPS for the current fiscal year.
OSUR has been the subject of several research analyst reports. Canaccord Genuity reissued a “buy” rating and issued a $24.00 price objective on shares of OraSure Technologies in a report on Friday, February 2nd. Zacks Investment Research downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a report on Saturday, November 4th. BidaskClub downgraded OraSure Technologies from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 15th. Jefferies Group downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, ValuEngine downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $22.25.
ILLEGAL ACTIVITY WARNING: “Stephen S. Phd Tang Sells 23,333 Shares of OraSure Technologies, Inc. (OSUR) Stock” was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2018/02/21/stephen-s-phd-tang-sells-23333-shares-of-orasure-technologies-inc-osur-stock.html.
About OraSure Technologies
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.